Ausbil Investment Management LTD Medpace Holdings, Inc. Transaction History

Ausbil Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$372.0 - $424.34 $651,000 - $742,595	1,750 Added 25.09%	8,724 $3.59 Billion
Q1 2024 Apr 15, 2024	BUY	$284.87 - $413.31 $428,444 - $621,618	1,504 Added 27.5%	6,974 $2.78 Billion
Q4 2023 Jan 10, 2024	BUY	$227.52 - $312.68 $14,333 - $19,698	63 Added 1.17%	5,470 $1.68 Billion
Q3 2023 Oct 10, 2023	BUY	$233.98 - $281.67 $555,702 - $668,966	2,375 Added 78.33%	5,407 $1.31 Billion
Q2 2023 Jul 11, 2023	SELL	$187.26 - $240.17 $627,321 - $804,569	-3,350 Reduced 52.49%	3,032 $728 Million
Q1 2023 May 01, 2023	BUY	$174.31 - $239.52 $1.11 Million - $1.53 Million	6,382 New	6,382 $1.2 Billion

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Ausbil Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Ausbil Investment Management LTD with notifications on news.